Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 3,139,435 |
|
|||||
| News | - | ||||||
| Day High | 127.32 | Low High |
|||||
| Day Low | 125.35 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Novo Nordisk | NVO | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -3.41 | -2.65% | 125.2339 | 18:51:36 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 127.15 | 125.35 | 127.32 | 126.16 | 128.64 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 54,142 | 3,139,435 | $ 126.06 | $ 395,767,065 | - | 75.56 - 138.28 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:49:43 | 1 | $ 125.395 | USD |
Novo Nordisk (NVO) Options Flow Summary
Novo Nordisk Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 571.87B | 4.51B | - | 232.26B | 83.68B | 18.56 | 6.83 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Novo Nordisk News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 124.95 | 128.76 | 122.46 | 124.71 | 3,809,266 | 0.2839 | 0.23% |
| 1 Month | 128.33 | 130.16 | 121.79 | 125.57 | 3,570,378 | -3.10 | -2.41% |
| 3 Months | 112.13 | 138.28 | 112.13 | 125.39 | 5,111,995 | 13.10 | 11.69% |
| 6 Months | 96.35 | 138.28 | 92.94 | 114.07 | 4,586,829 | 28.88 | 29.98% |
| 1 Year | 85.38 | 138.28 | 75.56 | 106.18 | 3,421,962 | 39.85 | 46.68% |
| 3 Years | 36.875 | 138.28 | 36.6225 | 84.36 | 2,019,365 | 88.36 | 239.62% |
| 5 Years | 24.44 | 138.28 | 23.00 | 67.18 | 1,765,047 | 100.79 | 412.41% |
Novo Nordisk Description
| Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders. |
